Prevalent expression of the IR-A over the IR-B has been discovered in several cancer models, and an autocrine proliferative loop between IGF-II and the IR-A has been detected in malignant thyrocytes, breast cancer, and sarcoma cells (16–19). Here, IGF2 is linked to cancer.